This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Feb;133(2):294-6.

doi: 10.1016/s0002-9394(01)01291-0.

Prognosis for placebo-treated eyes in VIP report 2

Stefano Da Pozzo, Maurizio Battaglia Parodi

PMID: 11812454
DOI: 10.1016/s0002-9394(01)01291-0

Comment

Prognosis for placebo-treated eyes in VIP report 2

Stefano Da Pozzo et al. Am J Ophthalmol. 2002 Feb.

. 2002 Feb;133(2):294-6.

doi: 10.1016/s0002-9394(01)01291-0.

Authors

Stefano Da Pozzo, Maurizio Battaglia Parodi

PMID: 11812454
DOI: 10.1016/s0002-9394(01)01291-0

No abstract available

PubMed Disclaimer

Comment on

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
Verteporfin In Photodynamic Therapy Study Group. Verteporfin In Photodynamic Therapy Study Group. Am J Ophthalmol. 2001 May;131(5):541-60. doi: 10.1016/s0002-9394(01)00967-9. Am J Ophthalmol. 2001. PMID: 11336929 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science